Business

Know the Business

Daqo is a pure-play, low-cost polysilicon refinery whose earnings power is set almost entirely by a single commodity price it cannot control. Two-thirds of its market cap is parked as cash on the balance sheet. The right way to read this stock: a debt-free option on the next polysilicon up-cycle, not a normal industrial. The market is probably under-pricing the optionality from China's "anti-involution" capacity discipline and over-pricing the depreciation drag from idle Phase 5 capacity.

1. How This Business Actually Works

Daqo turns electricity and metallurgical-grade silicon into a single product — high-purity polysilicon — and sells every kilogram into the Chinese solar wafer supply chain at the prevailing spot price. Profit is whatever ASP minus all-in cost happens to be that quarter, multiplied by however many tons the market will absorb. There is no recurring revenue, no installed base, no take-or-pay; every quarter resets.

Two inputs drive the cost structure: cheap thermal-coal electricity (~35% of production cost) and metallurgical silicon (~30%). Daqo's edge is geographic — plants in Xinjiang and Inner Mongolia where regional coal grids deliver some of the world's lowest industrial power rates, with in-house chlorine recovery further lowering variable cost. That cost advantage is the entire moat. It produced an all-in cash cost of $4.46/kg in Q4 2025, a company record, while peers in coastal China and Germany run materially higher.

The Economic Engine Step by Step

Operating Leverage — The Double-Edged Sword

Once a polysilicon line runs, depreciation, baseline electricity contracts, and skeleton labor are sunk; every additional kilogram drops to gross profit. That is why FY2022 produced a 73.9% gross margin and FY2025 a -20.7% gross margin — operating leverage cuts both ways, and idle Phase 5 capacity now amplifies losses through depreciation rather than direct cost. Daqo paused its newest 100,000 MT Phase 5B and the 1,000 MT semiconductor-grade lines in 2025 specifically to stop bleeding through them.

Unit Economics: The Quarterly ASP vs Cost Picture

The quarterly unit economics table is the single most important exhibit. In Q1-Q2 2025, ASP sat below total cost and near cash cost — every kilogram sold destroyed value. By Q4 2025 and into Q1 2026, ASP converged with total cost, meaning the business was roughly breakeven before inventory adjustments. The inflection is real but fragile: Q1 2026 ASP was $5.96/kg against total cost of $5.95/kg, yet sales volume collapsed to 4,482 MT because management chose not to chase below-cost transactions in a still-thin market.

Annual Cash Flow Cycle

Global solar installations grew in 2025, but Daqo's revenue fell 35% and gross margin stayed negative because polysilicon supply was the binding variable. This is the classic commodity trap: demand growth is necessary, but not sufficient.

Revenue Model and Pricing Power

Bargaining power is one-sided. Polysilicon is a fungible chemical input, and Daqo's customers are large vertically-integrated Chinese wafer/module producers who can buy from any of six major Chinese suppliers. The pricing convention — framework volumes, spot pricing at order — means Daqo absorbs price risk on every batch. The contracts may bind volume, but they do not give Daqo pricing power.

The cost edge is real, but it is not a moat in the pricing sense. It buys Daqo staying power in a downturn; it does not stop Tongwei, GCL, Xinte, or other Chinese capacity from setting the market price.

2. Is This Business Cyclical?

Polysilicon is the single most violently cyclical large-cap commodity in the listed solar supply chain. Daqo's gross margin has swung from +80% in Q3 2022 to -108% in Q2 2025 — a 188-point range over eleven quarters. Revenue per quarter ran from $1.28B to $75M over the same window. Both extremes were driven almost entirely by a single variable: polysilicon ASP, which moved from peaks above $30/kg in 2022 to roughly $5/kg through 2024 and the first half of 2025.

Where does the cycle hit? Three places, in order:

1. ASP first. ASP collapses when industry capacity laps demand — China's nameplate polysilicon capacity is now over 3 million MT against roughly 1.4 million MT of demand.
2. Utilization second. Daqo ran 33% capacity utilization in Q1 2025 and pulled it to 55% by Q4 by sequentially idling older Xinjiang lines.
3. Impairments last. Inventory and PP&E impairments follow; Daqo took a $176M long-lived-asset impairment in 2024 and an $18M-19M credit-loss reserve each of the last two years for receivables from a local-government infrastructure entity whose tax base collapsed with the industry.

This is not the first cycle. The 2011-2013 polysilicon glut bankrupted multiple Western producers and forced LDK Solar into receivership; ASP fell from $80/kg to under $20/kg. Daqo survived that round by relocating from Chongqing to Xinjiang for cheaper power, and emerged as a low-cost winner. The current trough is structurally similar but quantitatively worse on the supply side, and the policy response is more aggressive.

3. The Metrics That Actually Matter

Standard ratios are mostly noise here. P/E is meaningless when earnings are negative; ROE is meaningless when the business is mid-cycle; book value is suspect when 53% of total assets are PP&E that may face further impairment. The useful dashboard is unit spread, utilization, cash cost, liquidity, and capital-cycle discipline.

The chart above is the entire investment thesis on one axis. When the orange ASP line is above the blue cost line, Daqo prints money disproportionately to revenue. When ASP is below cost — which it has been for two consecutive years — every kilogram sold loses money. The bull case is not that demand explodes; it is that ASP crosses back above the cost line and stays there. That requires marginal Chinese capacity to exit, not just idle.

Unit spread deserves the most attention because it explains why a company with good technology, large scale, and no financial debt can still report large losses. Liquidity matters second because it lets Daqo refuse uneconomic volume — but liquidity is only valuable if management allocates it better than the industry allocated capital in the last upcycle.

4. What I'd Tell a Young Analyst

Stop modeling this like a normal industrial. There is no through-cycle ROE to anchor on; there is only the cost curve, the policy regime, and the balance sheet. The right framework is: estimate Daqo's net cash and at-cost optionality value, and treat the production business as a free call on the next polysilicon upturn.

The asymmetry math. Net cash plus liquid investments is roughly $2.0B; market cap is roughly $2.0B; the entire production business is being valued near zero. If polysilicon ASP recovers to even $9-10/kg (well below the 2021 average) on stable 200k MT volume, Daqo could earn $400-600M annually. That is not a forecast — it is a sensitivity that explains the option value embedded in the stock.

Three things to actually watch through 2026:

1. The credibility of the RMB 53-54/kg policy floor. If sales-below-cost enforcement holds and the consolidation SPV starts forcing capacity exits — not just idling — the cycle will turn faster than consensus thinks. If enforcement slips, the floor breaks and the trough extends.

2. Daqo's cash cost gap to the industry. A $4.46/kg cash cost against an industry marginal cost near $7/kg means Daqo gets paid first in any recovery. Watch whether peers (especially Tongwei and Xinte) close that gap, because that is where the moat erodes.

3. What management does with $2.0B+ of cash. The buyback hesitation in the Q4 2025 call ("waiting for policy clarity") is rational but not free — every quarter of inaction at sub-book is shareholder value left on the table. The ideal use is opportunistic M&A of distressed Chinese capacity at scrap value during the consolidation phase. The worst use is another greenfield expansion into oversupply.

What the market may be overestimating: the speed and durability of the recovery. Anti-involution is real but slow; capacity exits take years, and Daqo's own Phase 5B and semi-grade lines are still on the book waiting to be turned back on. The thesis breaks if (a) marginal capacity does not exit, (b) cash burn resumes from policy reversal, or (c) management deploys cash into new capacity instead of share repurchases or distressed M&A. Underwrite Daqo as a survival-and-spread recovery story, not as a permanently advantaged compounder.